Page last updated: 2024-08-23

paroxetine and Stroke

paroxetine has been researched along with Stroke in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (47.06)29.6817
2010's8 (47.06)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Cohen, L; Crépin, P; Del Cul, A; El Hachem, R; Guérineau de Lamérie, G; Kas, A; Morin, A; Ponchel, A; Ströer, S1
Han, L; Han, Z; Li, L; Yan, B1
Campbell Burton, CA; Chun, HY; Gillespie, D; Holmes, J; Knapp, P; Lewis, SR; Lightbody, CE; Murray, J; Watkins, CL1
Jiao, Y; Liang, Y; Lin, J; Qu, H; Sun, Y; Xu, J; Zhao, C1
Li, P; Ma, C1
Chen, W; Geng, D; Huang, Y; Li, Y; Shi, X; Wu, X1
Chino, A; Kasahara, Y; Namiki, T; Ogawa, K; Okamoto, H; Terasawa, K; Ueda, K1
Campbell Burton, CA; Gillespie, D; Holmes, J; Knapp, P; Lightbody, CE; Murray, J; Watkins, CL1
Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE1
Christensen, J; Clemmensen, PM; Dalsgaard, NJ; Dam, H; Hindberg, I; Lunde, M; Mellerup, E; Plenge, P; Rasmussen, A1
Ramasubbu, R2
de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P1
Andor, G; Harcos, P; Horváth, S; Karányi, Z; Nagy, Z; Németh, G1
Erfurth, A; Floreanu, A; Loew, M; Wendler, G1
Devarajan, S; Dursun, SM; Haddad, PM1
Antonucci, G; Bragoni, M; Coiro, P; De Angelis, D; Grasso, MG; Morelli, D; Paolucci, S; Rizzi, F; Troisi, E1

Reviews

5 review(s) available for paroxetine and Stroke

ArticleYear
Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:5

    Topics: Affect; Antidepressive Agents, Second-Generation; Depression; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Stroke; Time Factors; Treatment Outcome

2020
Interventions for treating anxiety after stroke.
    The Cochrane database of systematic reviews, 2017, 05-23, Volume: 5

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Buspirone; Depression; Humans; Middle Aged; Paroxetine; Pilot Projects; Psychotherapy; Randomized Controlled Trials as Topic; Relaxation Therapy; Stroke

2017
Interventions for treating anxiety after stroke.
    The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Buspirone; Humans; Paroxetine; Psychotherapy; Randomized Controlled Trials as Topic; Stroke

2011
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11

    Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation

2012
Pharmacotherapy of aphasia: myth or reality?
    Brain and language, 2007, Volume: 102, Issue:1

    Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Dopamine Agents; Fluoxetine; GABA Agonists; Humans; Indans; Neuroprotective Agents; Paroxetine; Physostigmine; Piperidines; Piracetam; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Stroke; Zolpidem

2007

Trials

2 trial(s) available for paroxetine and Stroke

ArticleYear
Platelet serotonin transporter in stroke patients.
    Acta neurologica Scandinavica, 2003, Volume: 107, Issue:2

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Binding, Competitive; Biomarkers; Blood Platelets; Carrier Proteins; Chronic Disease; Depression; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Reference Values; Serotonin Plasma Membrane Transport Proteins; Stroke; Time Factors

2003
[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].
    Orvosi hetilap, 2006, Dec-17, Volume: 147, Issue:50

    Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression; Female; Follow-Up Studies; Humans; Hungary; Male; Middle Aged; Paroxetine; Prevalence; Quality of Life; Selective Serotonin Reuptake Inhibitors; Stroke; Time Factors; Treatment Outcome

2006

Other Studies

10 other study(ies) available for paroxetine and Stroke

ArticleYear
Recovery from cortical blindness with mepivacaïne.
    Annals of clinical and translational neurology, 2019, Volume: 6, Issue:8

    Topics: Blindness, Cortical; Brain; Cerebral Cortex; Humans; Magnetic Resonance Imaging; Male; Mepivacaine; Middle Aged; Paroxetine; Stroke

2019
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
    BMJ open, 2017, Aug-03, Volume: 7, Issue:8

    Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder; Doxepin; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Paroxetine; Patient Acceptance of Health Care; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome

2017
Effectiveness of paroxetine in the treatment of poststroke depression.
    Medicine, 2018, Volume: 97, Issue:29

    Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Retrospective Studies; Stroke; Treatment Outcome

2018
Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy.
    Psychiatry research, 2010, Apr-30, Volume: 182, Issue:1

    Topics: Aged; Analysis of Variance; Antidepressive Agents; Aspartic Acid; Brain Mapping; Case-Control Studies; Choline; Depression; Dose-Response Relationship, Drug; Female; Functional Laterality; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Paroxetine; Stroke; Thalamus; Tritium

2010
A case of thalamic pain successfully treated with Kampo medicine.
    Journal of alternative and complementary medicine (New York, N.Y.), 2011, Volume: 17, Issue:6

    Topics: Aged; Analgesics; Diazepam; Female; Humans; Infarction; Medicine, Kampo; Movement Disorders; Nausea; Pain; Paroxetine; Phytotherapy; Plant Extracts; Sensation Disorders; Stroke; Thalamus

2011
Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:4

    Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Humans; Magnetic Resonance Imaging; Male; Paroxetine; Severity of Illness Index; Stroke; Substance Withdrawal Syndrome

2003
Antidepressant treatment-associated behavioural expression of hypomania: a case series.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:7

    Topics: Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Irritable Mood; Ischemic Attack, Transient; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Stroke

2004
[Depressive disorders in neurologic rehabilitation: therapy with paroxetine].
    Psychiatrische Praxis, 2001, Volume: 28, Issue:1

    Topics: Adult; Aged; Brain Diseases; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Stroke; Stroke Rehabilitation; Treatment Outcome

2001
Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.
    Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:2

    Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Diagnosis, Differential; Dysthymic Disorder; Female; Humans; Paroxetine; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

2001
Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study.
    Cerebrovascular diseases (Basel, Switzerland), 2001, Volume: 12, Issue:3

    Topics: Activities of Daily Living; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Case-Control Studies; Depression; Disabled Persons; Female; Fluoxetine; Humans; Male; Middle Aged; Motor Activity; Paroxetine; Recovery of Function; Stroke; Stroke Rehabilitation

2001